BNTC
Benitec Biopharma Ltd
9.80$
-10.2%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Income Statement
Tick rows to compare them in a chart (up to 4)
| Line item | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.1 | 0.5 | 2.3 | 0.4 | 0.3 | 0.2 | 0.2 | 0.1 | 0.3 | 0.5 | 1.0 | 0.6 | 0.3 | 0.2 | 4.4 | 17 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.0 | – | |
| – | 1.4 | – | 1.2 | 2.5 | 1.7 | 1.6 | 1.0 | 1.2 | 0.2 | 0.0 | 0.0 | 0.1 | 0.2 | 0.5 | 0.6 | -0.2 | 0.1 | 0.0 | 0.4 | 0.3 | 0.4 | – | |
| – | -0.9 | 2.3 | -0.8 | -2.3 | -1.4 | -1.4 | -0.9 | -0.9 | 0.3 | 0.9 | 0.6 | 0.2 | 0.0 | 3.9 | 16 | 0.3 | -0.1 | 0.1 | 0.1 | -0.3 | -0.4 | – | |
| 1.0 | 3.0 | 2.2 | – | 0.6 | 1.0 | 1.3 | 1.2 | 1.3 | 3.2 | 5.5 | 3.6 | 7.4 | 4.1 | 3.7 | 3.2 | 3.0 | 7.0 | 11 | 13 | 16 | 18 | 23 | |
| – | – | – | – | – | – | – | – | – | 4.1 | 7.2 | 4.7 | 6.5 | 5.4 | 4.7 | 3.2 | 5.6 | 6.5 | 6.6 | 6.4 | 7.0 | 23 | 28 | |
| 7.9 | 14 | 4.3 | 0.5 | 0.5 | 1.0 | 1.3 | 2.0 | 3.5 | 7.9 | 14 | 11 | 19 | 12 | 17 | 13 | 8.6 | 14 | 18 | 19 | 22 | 41 | 51 | |
| -8.7 | -15 | -1.9 | -1.3 | -2.8 | -2.5 | -2.7 | -2.9 | -4.4 | -7.5 | -14 | -10 | -19 | -16 | -8.7 | 3.7 | -8.3 | -14 | -18 | -19 | -22 | -42 | -51 | |
| 0.0 | 0.2 | – | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.9 | 3.3 | – | |
| -7.9 | -7.1 | -0.5 | -1.9 | -2.6 | -2.4 | -4.8 | -3.3 | -4.2 | -6.3 | -10 | -6.7 | -14 | -3.3 | -8.6 | 3.7 | -8.3 | -14 | -18 | -20 | -22 | -38 | -46 | |
| – | – | – | – | – | -0.1 | – | – | – | -0.4 | -4.0 | 0.8 | -9.0 | -10 | -4.2 | -0.9 | 0.0 | -0.1 | 0.4 | 0.0 | -0.6 | – | – | |
| -7.9 | -14 | -7.8 | -2.5 | -2.6 | -2.3 | -4.8 | -3.3 | -4.2 | -3.9 | -6.9 | -6.7 | -14 | -5.6 | -12 | 3.7 | -8.3 | -14 | -18 | -20 | -22 | -38 | -46 | |
| -7.0 | -13 | -1.9 | -1.3 | -2.8 | -2.5 | -2.7 | -2.9 | -4.4 | -6.2 | -9.7 | -6.0 | -21 | -3.2 | -6.3 | 1.9 | -7.9 | -13 | -18 | -19 | -22 | -41 | -51 |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.